SCHEMBL5478263

SCHEMBL5478263

CCOC(=O)c1cc(=O)n(COCC[Si](C)(C)C)cn1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.40
DGAT1 O75907 4/20 0.39
ALDH1A1 P00352 3/20 0.38
MAPT P10636 3/20 0.38
KDM4E B2RXH2 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HPGD P15428 1/20 0.38
TSHR P16473 1/20 0.38
CASP1 P29466 1/20 0.38
HSD17B10 Q99714 1/20 0.38
GABRP O00591 6/20 0.38
GABRD O14764 6/20 0.38
GABRA1 P14867 6/20 0.38
GABRB1 P18505 6/20 0.38
GABRG2 P18507 6/20 0.38
GABRB3 P28472 6/20 0.38
GABRA5 P31644 6/20 0.38
GABRA3 P34903 6/20 0.38
GABRA2 P47869 6/20 0.38
GABRB2 P47870 6/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5488835 0.85 NPC1 (0.36) DGAT1ALDH1A1MAPTKDM4ESMN1; SMN2
SCHEMBL5485859 0.81 NPC1 (0.36) DGAT1MAPTTSHRHSD17B10NPC1
SCHEMBL27094264 0.81 ALDH1A1 (0.38) DGAT1ALDH1A1MAPTKDM4ESMN1; SMN2
SCHEMBL2960376 0.79 CA12 (0.40) ALDH1A1MAPTHPGDNPC1
SCHEMBL14255842 0.79 ALDH1A1 (0.44) DGAT1ALDH1A1MAPTKDM4ESMN1; SMN2
SCHEMBL20168404 0.79 NOTUM (0.43) NOTUMDGAT1ALDH1A1MAPTKDM4E
SCHEMBL3528543 0.77 MAPT (0.43) DGAT1ALDH1A1MAPTSMN1; SMN2TSHR
SCHEMBL3023087 0.77 DGAT1 (0.38) DGAT1ALDH1A1MAPTKDM4ESMN1; SMN2
SCHEMBL16100174 0.77 DGAT1 (0.38) DGAT1ALDH1A1MAPTKDM4ESMN1; SMN2
SCHEMBL7431910 0.76 DGAT1 (0.49) DGAT1ALDH1A1KDM4EHPGDGABRA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070259860-A1 MGluR5 modulators V ASTRAZENECA AB (SE) 2007-11-08 US claimed
US-20070259860-A1 MGluR5 modulators V ASTRAZENECA AB (SE) 2007-11-08 US disclosed
US-20070259860-A1 MGluR5 modulators V ASTRAZENECA AB (SE) 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259860-A1 MGluR5 modulators V GRM5, GRIK5, GRM2 NOTUM 2476/4885DGAT1 1498/4885ALDH1A1 4603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.